Neurovascular Devices | Market Insights | US | 2024
The US neurovascular device market will see moderate growth through 2032 driven by the growing adoption of thrombectomy for
managing acute ischemic stroke, the launch of new embolization and thrombectomy devices that treat expanded indications, as well
as the continued expansion of infrastructure dedicated to facilitating neurovascular interventions.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for stroke devices in the US from
2019 through 2032
